Immunogenetics of Hashimoto's thyroiditis

Journal of Autoimmune Diseases

Volumn 2, Issue , 2005, Pages

  Chistiakov, Dimitry A ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ANTIBODY SPECIFICITY; APOPTOSIS; AUTOIMMUNITY; CELLULAR IMMUNITY; CLINICAL FEATURE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HASHIMOTO DISEASE; HLA SYSTEM; HUMAN; IMMUNOGENETICS; IMMUNOREGULATION; NONHUMAN; PATHOGENESIS; REVIEW; T LYMPHOCYTE;

EID: 18044390659     PISSN: 17402557     EISSN: 17402557     Source Type: Journal    
DOI: 10.1186/1740-2557-2-1     Document Type: Review

References (259)

1. Vanderpump MP, Tunbridge WM: Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002, 12:839-847.
2. Wang C, Crapo LM: The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997, 26:189-218.
3. Tunbridge WM, Vanderpump MP: Population screening for autoimmune thyroid disease. Endocrinol Metab Clin North Am 2000, 29:239-253.
4. 4, and thyroid antibodies in the United states population (1988 to 1994): National health and Nutrition Examination Durvey (NHALES III). J Clin Endocrind Metab 2002, 87:489-499.
5. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA: The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977, 7:481-493.
6. Okamura K, Ueda K, Sone H, Ikenoue H, Hasuo Y, Sato K, Yoshinary M, Fujishima M: A sensitive thyroid hormone assay for screening a thyroid functional disorder in elderly Japanese. J Am Geriatr Soc 1989, 37:317-322.
7. Gordin A, Heinonen OP, Saarinen P, Lamberg BA: Serum thyrotropin in symptomless autoimmune thyroiditis. Lancet 1972, 1:551-554.
8. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley EJ, Hasan D, Rodgers H, Tunbridge F, Young ET: The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43:55-69.
9. Hueston WJ: Treatment of hypothyroidism. Am Fam Physician 2001, 64:1717-1724.
10. Devendra D, Eisenbarth GS: 17. Immunological endocrine disorders. J Allergy Clin Immunol 2003, 111:624-636.
11. Jenkins RC, Weetman AP: Disease associations with autoimmune thyroid disease. Thyroid 2002, 12:977-988.
12. Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C, Lind L, Holmgren G, Holmberg M, Asplund K, Holmberg D: The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur J Hum Genet 2003, 11:81-84.
13. Niederwieser G, Buchinger W, Bonelli RM, Berghold A, Reisecker F, Koltringer P, Archelos JJ: Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J Neurol 2003, 250:672-675.
14. Zettinig G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M: Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol 2003, 131:347-354.
15. Betterle C, Zanchetta R: Update on autoimmune polyendocrine syndromes (APS). Acta Biomed Ateneo Parmense 2003, 74:9-33.
16. Rose NR, Saboori AM, Rasooly L, Burek CL: The role of iodine in autoimmune thyroiditis. Crit Rev Immunol 1997, 17:511-517.
17. Rose NR, Bonita R, Burek CL: Iodine: an environmental trigger of thyroiditis. Autoimmun Rev 2002, 1:97-103.
18. Tomer Y, Davies TF: Infection, thyroid disease and autoimmunity. Endocrine Rev 1993, 14:107-120.
19. Mine H, Kawai H, Yokoi K, Akaike M, Saito S: High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with antithyroid antibodies. J Mol Med 1996, 74:471-477.
20. Kakizaki S, Takagi H, Murakami M, Takayama H, Mori M: HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. J Hepatol 1999, 30:794-800.
21. Imaizumi M, Pritsker A, Kita M, Ahmad L, Unger P, Davies T: Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies. Endocrinology 2001, 142:823-829.
22. Tomer Y: Genetic dissection of familial autoimmune thyroid diseases using whole genome screening. Autoimmun Rev 2002, 1:198-204.
23. Boukis MA, Koutras DA, Souvatzoglou A, Evangepolou K, Vrontakis M, Moulapoulaos SD: Thyroid hormone and immunologic studies in endemic goiter. J Clin Endocrinol Metab 1983, 57:859-862.
24. Harach HR, Eslacante DA, Onativia A, Lederer Outes J, Saravia Day E, Williams ED: Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine phospholaxis. Acta Endocrinol 1985, 108:55-60.
25. Allen EM, Appel MC, Braverman LE: The effect of iodide ingestion on the development of spontaneous lympholytic thyroiditis in the diabetesprone BB/W rat. Endocrinology 1986, 118:1977-81.
26. Rasooly L, Burek CL, Rose NR: Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol 1996, 81:287-292.
27. Ruwhof C, Draxhage HA: Iodine and thyroid autoimmune disease in animal models. Thyroid 2001, 11:427-436.
28. Kabel PJ, Voorbij HA, de Haan M, van der Gaag RD, Drexhage HA: Intarthyroidal dendritic cells. J Clin Endocrinol Metab 1988, 66:199-207.
29. Many M-C, Maniratunga S, Varis I, Dardenne M, Draxhage HA, Denef J-F: Two-step development of a Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic (NOD) mice. Effects of iodine-induced cell necrosis. J Endocrinol 1995, 147:311-320.
30. Wan Q, Shah R, Panos JC, Giraldo AA, David CS, Kong YM: HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible. Hum Immunol 2002, 63:301-310.
31. Wan XL, Kimura A, Dong RP, Honda K, Tamai H, Sasazuki T: HLAA and -DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis. Hum Immunol 1995, 42:131-136.
32. Vasu C, Gorla SR, Prabhakar BS: Targeted engagement of CTLA-4 prevents autoimmune thyroiditis. Int Immunol 2003, 15:641-654.
33. Greiner DL, Handler ES, Nakano K, Mordes JP, Rossini AA: Absence of the RT-6 T cells in diabetes-prone BB/W rats. J Immunol 1986, 136:148-151.
34. Wick G, Brezinschek HP, Hala K, Dietrich H, Wolf H, Kroemer G: The obese strain of chickens: an animal model for sponataneous autoimmune thyroiditis. Adv Immunol 1989, 47:433-500.
35. Martin A, Davies TF: T cells and human autoimmune thyroid disease: emerging data show lack of need to invoke suppressor T cell problems. Thyroid 1992, 2:247-261.
36. Bottazzo GF, Pujol-Borell R, Hanafusa T, Feldmann M: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983, 2:1115-1118.
37. Rapoport B, McLachlan SM: Thyroid autoimmunity. J Clin Invest 2001, 108:1253-1259.
38. Shimojo N, Kohno Y, Yamaguchi K, Kikuoka S, Hoshioka A, Niimi H, Hirai A, Tamura Y, Saito Y, Kohn LD, Tahara K: Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA 1996, 93:11074-11079.
39. Jaume JC, Guo J, Wang J, Rapoport B, McLachlan SM: Cellular thyroid peroxidase (TPO), unlike purified TPO and adjuvant, induces antibodies in mice that resemble autoantibodies in human autoimmune thyroid disease. J Clin Endocrinol Metab 1999, 84:1651-1657.
40. Champion BR, Page KR, Parish N, Rayner DC, Dawe K, Biswas-Hughes G, Cooke A, Geysen M, Roitt IM: Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells. J Exp Med 1991, 174:363-370.
41. Rasooly L, Rose NR, Saboori AM, Ladenson PW, Burek CL: Iodine is essential for human T cell recognition of human thyroglobulin. Autoimmunity 1998, 27:213-219.
42. Ebner SA, Lueprasitsakul W, Alex S, Fang SL, Appel MC, Braverman LE: Iodine content of rat thyroglobuline affects its autogenicity in inducing lympholytic thyroiditis in the BB/Wor rat. Autoimmunity 1992, 13:209-214.
43. Mahmoud I, Colin I, Many MC, Denef JF: Direct toxic effect effect of iodide in excess on iodine-deficient thyroid gland: epithelial necrosis and inflammation associated with lipofuscin accumulation. Exp Mol Pathol 1986, 44:259-271.
44. Simons PJ, Delamarre FG, Drexhage HA: Antigen-presenting dendritic cells as regulators of the growth of thyrocytes: a role for interleukin-1 beta and interleukin-6. Endocrinology 1998, 139:3148-3156.
45. Lamas L, Anderson PC, Fox JW, Dunn JT: Consensus sequences for early iodination and hormonogenesis in human thyroglobulin. J Biol Chem 1989, 264:13541-13545.
46. Male DK, Champion BR, Pryce G, Matthews H, Shepherd P: Antigenic determinans of human thyreoglobulin differentiated using antigen fragments. Immunology 1985, 54:419-427.
47. Tomer Y: Anti-thyroglobulin autoantibodies in autoimmune thyroid diseases: cross-reactive or pathogenic? Clin Immunol Immunopathol 1997, 82:3-11.
48. Kohno T, Tsinetoshi Y, Ishikawa E: Existence of antithyroglobulin IgG in healthy subjects. Biochem Biophys Res Commun 1988, 155:224-229.
49. Piechaszuk M, Bouananni M, Salhi SL, Baldet L, Bastide M, Pau B, Bastide JM: Antigenic domains of the human thyroglobulin molecule recognized by autoantibodies in patients' sera and by natural autoantibodies isolated from sera of healthy subjects. Clin Inmunol Immunopathol 1987, 45:114-121.
50. Dietrich G, Piechaszuk M, Pau B, Kasatchkine MD: Evidence for a restricted idiotypic and epitopic specificity of anti-thyroglobulin autoantibodies in patients with autoimmune thyroiditis. Eur J Immunol 1991, 21:811-814.
51. Taneja V, David CS: HLA transgenic mice as humanized mouse models of disease and immunity. J Clin Invest 1998, 101:921-926.
52. Kong YM, David CS, Lomo LC, Fuller BE, Motte RW, Giraldo AA: Role of mouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis. Immunogenetics 1997, 46:312-317.
53. Dunn JT, Dunn AD: Update on the intrathyroidal iodine metabolism. Thyroid 2001, 11:407-414.
54. McLachlan SM, Rapoport B: Genetic and epitopic analysis of thyroid peroxidase (TPO) autoantibodies: markers of the human thyroid autoimmune response. Clin Exp Immunol 1995, 101:200-206.
55. Chardes T, Chapal N, Bresson D, Bes C, Giudicelli V, Lefranc MP, Peraldi-Roux S: The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases. Immunogenetics 2002, 54:141-157.
56. Akamizu T: Antithyrotropin receptor antibody: an update. Thyroid 2001, 11:1123-1134.
57. Heufelder AE, Joba W, Morgenthaler NG: Autoimmunity involving the human sodium/iodide symporter: fact or fiction? Exp Clin Endocrinol Diabetes 2001, 109:35-40.
58. Blucher H, Krohn K, Wallaschofski H, Braverman LE, Paschke R: Cytokine gene expression in autoimmune thyroiditis in Bio-Breeding/Worcester rats. Thyroid 1999, 9:1049-1055.
59. Mooij P, de Wit HJ, Drexhage HA: An excess of dietary iodine accelerates the development of thyroid-associated lymphoid tissue in autoimmune prone BB rats. Clin Immunol Immunopathol 1993, 69:189-198.
60. Blucher H, Krohn K, Wallaschofski H, Braverman LE, Paschke R: Fas and Fas ligand gene expression in autoimmune thyroiditis in BB/W rats. Eur J Endocrinol 1999, 141:506-511.
61. Salmaso C, Bagnasco M, Pesce G, Montagna P, Brizzolara R, Altrinetti V, Richiusa P, Galluzzo A, Giordano C: Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. Ann N Y Acad Sci 2002, 966:496-501.
62. Weetman AP: Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003, 148:1-9.
63. Eguchi K: Apoptosis in autoimmune diseases. Intern Med 2001, 40:275-284.
64. Stassi G, De Maria R: Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2002, 21:195-204.
65. Giordano C, Richiusa P, Bagnasco M, Pizzolanti G, Di Blasi F, Sbriglia MS, Mattina A, Pesce G, Montagna P, Capone F, Misiano G, Scorsone A, Pugliese A, Galluzzo A: Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid 2001, 11:233-244.
66. Limachi F, Basso S: Apoptosis: life trough planned cellular death regulating mechanisms, control systems, and relations with thyroid disease. Thyroid 2002, 12:27-34.
67. Giordano C, Stassi G, De Maria R, Todaro M., Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997, 275:960-963.
68. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytolytic T-cell cytotoxity is mediated through perforin and Fas lytic pathways. Nature 1994, 370:650-652.
69. Arscott PL, Baker JR Jr: Apoptosis and thyroiditis. Clin Immunol Immunopathol 1998, 87:207-217.
70. Zaccone P, Fehervari Z, Cooke A: Tumour necrosis factor-α is a fundamental cytokine in autoimmune thyroid disease induced by thyroglobulin and lypopolysacharide in interleukin-12 p40 deficient C57BL/6 mice. Immunology 2003, 108:50-54.
71. Strasser A., O'Connor L, Dixit VM: Apoptosis signalling. Annu Rev Biochem 2000, 69:217-245.
72. Bretz JD, Baker JR Jr: Apoptosis and autoimmune thyroid disease: following a TRAIL to thyroid destruction? Clin Endocrinol 2001, 55:1-11.
73. Hall R, Stanbury JB: Familial studies of autoimmune thyroiditis. Clin Exp Immunol 1967, 2(Suppl):719-725.
74. Tomer Y, Davies TF: Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003, 24:694-717.
75. Brix TH, Kyvik KO, Hegedus L: A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 2000, 85:536-539.
76. Ringold DA, Nicoloff JT, Kesler M, Davis H, Hamilton A, Mack T: Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid 2002, 12:647-653.
77. Phillips DI, Osmond C, Baird J, Huckle A, Rees-Smith B: Is birth-weight associated with thyroid autoimmunity? A study in twins. Thyroid 2002, 12:377-380.
78. Rose NR: Avian models of autoimmune disease: lessons from the birds. Poult Sci 1994, 73:984-990.
79. Lam-Tse WK, Lernmark A, Drexhage HA: Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? Springer Semin Immunopathol 2002, 24:297-321.
80. Stafford EA, Rose NR: Newer insights into the pathogenesis of experimental autoimmune thyroiditis. Int Rev Immunol 2000, 19:501-533.
81. Braley-Mullen H, Johnson M, Sharp GC, Kuriakos M: Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells. Cell Immunol 1985, 93:132-143.
82. Fuller BE, Giraldo AA, Waldmann H, Cobbold SP, Kong YC: Depletion of CD4+ and CD8+ cells eliminates immunologic memory of thyroiditogenicity in murine experimental autoimmune thyroiditis. Autoimmunity 1994, 19:161-168.
83. Caturegli P, Kuppers RC, Mariotti S, Burek CL, Pinchera A, Ladenson PW, Rose NR: IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clin Exp Immunol 1994, 98:464-469.
84. Gebe JA, Swanson E, Kwok WW: HLA class II peptide-binding and autoimmunity. Tissue Antigens 2002, 59:78-87.
85. Kong YM, Lomo LC, Motte RW, Giraldo AA, Baisch J, Strauss G, Hammerling GJ, David CS: HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med 1996, 184:1167-1172.
86. Flynn JC, Fuller BE, Giraldo AA, Panos JS, David CS, Kong JM: Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in non-obese diabetic mice. J Autoimmun 2001, 17:7-15.
87. Flynn JC, Wan Q, Panos JC, McCormick DJ, Giraldo AA, Davied CS, Kong YM: Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downredulate DR3-mediated thyroiditis. J Autoimmun 2002, 18:213-220.
88. Kong YM, David CS: New revelations in susceptibility to autoimmune thyroiditis by the use of H2 and HLA class II transgenic models. Int Rev Immunol 2000, 19:573-585.
89. Marguerie C, Lunardi C, So A: PCR-based analysis of the TCR repertoire in human autoimmune diseases. Immunol Today 1992, 13:336-338.
90. Matsuoka N, Bernard N, Concepcion ES, Graves PN, Ben-Nun A, Davies TF: T-cell receptor V region beta-chain gene expression in the autoimmune thyroiditis of non-obese diabetic mice. J Immunol 1993, 151:1691-1701.
91. Matsuoka N, Unger P, Ben-Nun A, Graves P, Davies TF: Thyroglobulin- induced murine thyroiditis assessed by intrathyroidal T cell receptor sequencing. J Immunol 1994, 152:2562-2568.
92. Quaratino S, Badami E, Pang YY, Bartok I, Dyson J, Kioussis D, Londei M, Maiuri L: Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nat Med 2004, 10:920-926.
93. Quaratino S, Feldmann M, Dayan CM, Acuto O, Londei M: Human self-reactive T cell clones expressing identical T cell receptor β chains differ in their ability to recognize a cryptic selfepitope. J Exp Med 1996, 183:349-358.
94. Salomon B, Bluestone JA: Complexes of CD28/B7-CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001, 19:225-252.
95. Greenwald RJ, Boussotis VA, Lorsbach RB, Abbas AK, Sharpe AH: CTLA-4 regulates induction of anergy in vivo. Immunity 2001, 14:145-155.
96. Eagar TN, Karandikar NJ, Bluestone JA, Miller SD: The role of CTLA-4 in induction and maintaince of peripheral T cell tolerance. Eur J Immunol 2002, 32:972-981.
97. Carreno BM, Bennett F, Chau TA, Ling V, Luxenberg D, Jussif J, Baroja ML, Madrenas J: CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 2000, 165:1352-1356.
98. Prud'homme GJ, Chang Y, Li X: Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand. Hum Gene Ther 2002, 13:395-406.
99. Campbell RD, Trowsdale J: Map of human MHC. Immunol Today 1993, 14:349-352.
100. Sakurami T, Ueno Y, Iwaki Y, Park MS, Terasaki PI, Saji H: HLA-DR specificities among Japanese with several autoimmune diseases. Tissue Antigens 1982, 19:129-133.
101. Hawkins BR, Lam KS, Ma JT, Wang CC, Yeung RT: Strong association between HLA DRw9 and Hashimoto's thyroiditis in Southern Chinese. Acta Endocrinol 1987, 114:543-546.
102. Ito M, Tanimoto M, Kamura H, Yoneda M, Morishima Y, Yamauchi K, Itatsu T, Takatsuki K, Saito H: Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 1989, 69:100-104.
103. Inoue D, Sato K, Maeda M, Inoko H, Tsuji K, Mori T, Imura H: Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1991, 34:57-62.
104. Inoue D, Sato K, Sugawa H, Akamizu T, Maeda M, Inoko H, Tsuji K, Mori T: Apparent genetic difference between hypothyroid patients with blocking-type thyrotropin receptor antibody and those without, as shown by restriction fragment length polymorphism analyses of HLA-DP loci. J Clin Endocrinol Metab 1993, 77:606-610.
105. Onuma H, Ota M, Sugenoya A, Fukushima H, Inoko H, Iida F: Association of HLA-DR53 and lack of association of DPB1 alleles with Hashimoto's thyroiditis in Japanese. Tissue Antigens 1993, 42:150-152.
106. Moens H, Farid NR, Sampson L, Noel EP, Barnard JM: Hashimoto's thyroiditis is associated with HLA-DRw3. N Engl J Med 1978, 299:133-134.
107. Weissel M, Hofer R, Zasmeta H, Mayr WR: HLA-DR and Hashimoto's thyroiditis. Tissue Antigens 1980, 16:256-257.
108. Farid NR, Sampson L, Moens H, Barnard JM: The association of goitrous autoimmune thyroiditis with HLA-DR5. Tissue Antigens 1981, 17:265-268.
109. Thomsen M, Ryder LP, Bech K, Bliddal H, Feldt-Rasmussen U, Molholm J, Kappelgaard E, Nielsen H, Svejgaard A: HLA-D in Hashimoto's thyroiditis. Tissue Antigens 1983, 21:173-175.
110. Tandon N, Zhang L, Weetman AP: HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1991, 34:383-386.
111. Stenszky V, Balazs C, Kraszits E, Juhasz F, Kozma L, Balazs G, Farid NR: Association of goitrous autoimmune thyroiditis with HLA-DR3 in eastern Hungary. J Immunogenet 1987, 14:143-148.
112. Badenhoop K, Schwarz G, Walfish PG, Drummond V, Usadel KH, Bottazzo GF: Susceptibility to thyroid autoimmune disease: molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 1990, 71:1131-1137.
113. Mangklabruks A, Cox N, DeGroot LJ: Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab 1991, 73:236-244.
114. Bogner U, Badenhoop K, Peters H, Schmieg D, Mayr WR, Usadel KH, Schleusener H: HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity 1992, 14:155-158.
115. Shi Y, Zou M, Robb D, Farid NR: Typing for major histocompatibility complex class II antigens in thyroid tissue blocks: association of Hashimoto's thyroiditis with HLA-DQA0301 and DQB0201 alleles. J Clin Endocrinol Metab 1992, 75:943-946.
116. Nicholson LB, Wong FS, Ewins DL, Butler J, Holland A, Demaine AG, McGregor AM: Susceptibility to autoimmune thyroiditis in Down's syndrome is associated with the major histocompatibility class II DQA 0301 allele. Clin Endocrinol (Oxf) 1994, 41:381-383.
117. Barbesino G, Chiovato L: The genetics of Hashimoto's disease. Endocrinol Metab Clin North Am 2000, 29:357-374.
118. Hunt PJ, Marshall SE, Weetman AP, Bunce M, Bell JI, Wass JA, Welsh KI: Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin Endocrinol 2001, 55:491-499.
119. Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Di Mario U, Buzzetti R: Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 2001, 11:171-175.
120. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y: The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin Endocrinol 2002, 57:81-88.
121. Wu Z, Stephens HA, Sachs JA, Biro PA, Cutbush S, Magzoub MM, Becker C, Schwartz G, Bottazzo GF: Molecular analysis of HLA-DQ and -DP genes in Caucasoid patients with Hashimoto's thyroiditis. Tissue Antigens 1994, 43:116-119.
122. Jenkins D, Penny MA, Fletcher JA, Jacobs KH, Mijovic CH, Franklyn JA, Sheppard MC: HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1992, 37:141-145.
123. Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH: Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 1995, 80:2112-2117.
124. Bode HH, Dorf ME, Forbes AP: Familial lympholytic thyroiditis: analysis of linkage with hitocompatibility and blood groups. J Clin Endocrinol Metab 1973, 37:692-697.
125. Hawkins BR, Ma JT, Lam KS, Wang CC, Yeung RT: Analysis of linkage between HLA haplotype and susceptibility to Graves' disease in multiple-case Chinese families in Hong Kong. Acta Endocrinol 1985, 110:66-69.
126. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF: Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 1992, 74:496-503.
127. O'Connor G, Neufeld DS, Greenberg DA, Concepcion ES, Roman SH, Davies TF: Autoimmunity 1993, 14:237-241.
128. Tomer Y, Barbesino G, Keddache M, Greenberg DA, Davies TF: Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J Clin Endocrinol Metab 1997, 82:1645-1648.
129. Barbesino G, Tomer Y, Concepcion ES, Davies TF, Greenberg DA: 1. Selected immunoregulatory genes. International Consortium for the Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab 1998, 83:1580-1584.
130. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF: Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 1999, 84:4656-4664.
131. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF: Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003, 73:736-747.
132. Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, Fox A, Miller C, Dills DG, Ridgway EC, Bennett DC, Fain PR, Spritz RA: Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 2002, 11:661-667.
133. Maalej A, Makni H, Ayadi F, Bellassoued M, Jouida J, Bouguacha N, Abid M, Ayadi H: A full genome screening in a large Tunisian family affected with thyroid autoimmune disorders. Genes Immun 2001, 2:71-75.
134. Villanueva R, Tomer Y, Greenberg DA, Mao C, Concepcion ES, Tucci S, Estilo G, Davies TF: Autoimmune thyroid disease susceptibility loci in a large Chinese family. Clin Endocrinol 2002, 56:45-51.
135. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T: Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 2001, 10:1379-1386.
136. Levin L, Ban Y, Concepcion E, Davies TF, Greenberg DA, Tomer Y: Analysis of HLA genes in families with autoimmune diabetes and thyroiditis. Hum Immunol 2004, 65:640-647.
137. Torfs CP, King MC, Huey B, Malmgren J, Grumet FC: Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis. Am J Hum Genet 1986, 38:170-187.
138. Payami H, Joe S, Thomson G: Autoimmune thyroid disease in type 1 diabetes. Genet Epidemiol 1989, 6:137-141.
139. Allen DB, MacDonald MJ, Gottschall JL, Hunter JB: Autoimmune thyroid phenomena are not evidence for human lymphocyte antigen-genetic heterogeneity in insulin-dependent diabetes. Am J Med Genet 1989, 33:405-408.
140. Djilali-Saiah I, Bertin E, Larger E, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S: Major histocompatibility class II genes polymorphism in insulin dependent diabetes mellitus with or without associated thyroid autoimmunity. Hum Immunol 1998, 59:176-182.
141. Fischer GF: Molecular genetics of HLA. Vox Sanguinis 2000, 78:261-264.
142. Faas S, Trucco M: The genes influencing the susceptibility to IDDM in humans. J Endocrinol Invest 1994, 17:477-495.
143. Sawai Y, DeGroot LJ: Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab 2000, 85:1176-1179.
144. Dawe KI, Hutchings PR, Geysen M, Champion BR, Cooke A, Roitt IM: Unique role of thyroxine in T cell recognition of a pathogenic peptide in experimental autoimmune thyroiditis. Int Rev Immunol 2000, 19:573-585.
145. Kuhr T, Hala K, Dietrich H, Herold M, Wick G: Genetically determined target organ susceptibility in the pathogenesis of spontaneous autoimmune thyroiditis: aberrant expression of MHC-class II antigens and the possible role of virus. J Autoimmun 1994, 7:13-25.
146. Kong JM: Graves' hyperthyroidism and thyroiditis in HLA-DRB1* 0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA. Clin Exp Immunol 2004, 135:35-40.
147. Londei M, Lamb JR, Bottazzo GF, Feldmann M: Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 1984, 312:639-641.
148. Hamilton F, Black M, Farquharson MA, Stewart C, Foulis AK: Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease. Clin Exp Immunol 1991, 83:64-68.
149. Shimojo N, Arima T, Yamaguchi K, Kikuoka S, Kohn LD, Kohno Y: A novel mouse model of Graves' disease: implications for a role of aberrant MHC class II expression in its pathogenesis. Int Rev Immunol 2000, 19:619-631.
150. Platzer M, Neufeld DS, Piccinini LA, Davies TF: Induction of rat thyroid cell MHC class II antigen by thyrotropin and gammainterferon. Endocrinology 1987, 121:2087-2092.
151. Nagataki S, Eguchi K: Cytokines and immune regulation in thyroid autoimmunity. Autoimmunity 1992, 13:27-34.
152. Todd JA: Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci USA 1995, 92:8560-8565.
153. Lewin L, Tomer Y: The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun Rev 2003, 2:377-386.
154. Makhatadze NJ: Tumor necrosis factor locus: genetic organisation and biological implications. Hum Immunol 1998, 59:571-579.
155. Milner CM, Campbell RD: Genetic organization of the human MHC class III region. Front Biosci 2001, 6:D914-926.
156. Weetman AP, Ajjan RA, Watson PF: Cytokines and Graves disease. Baillieres Clin Endocrinol Metab 1997, 11:481-497.
157. Chung JH, Cho BY, Lee HK, Kim TG, Han H, Koh CS: The tumor necrosis factor beta * 1 allele is linked significantly to HLADR8 in Koreans with atrophic autoimmune thyroiditis who are positive for thyrotropin receptor blocking antibody. J Korean Med Sci 1994, 9:155-161.
158. De Nagel DC, Pierce SK: Heat shock proteins implicated in antigen processing and presentation. Semin Immunol 1991, 3:65-71.
159. Parkes AB, Darke C, Othman S, Thomas M, Young N, Richards CJ, Hall R, Lazarus JH: Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditis. Eur J Endocrinol 1996, 134:449-453.
160. Fu Y, Yan G, Shi L, Faustman D: Antigen processing and autoimmunity. Evaluation of mRNA abundance and function of HLA-linked genes. Ann N Y Acad Sci 1998, 842:138-155.
161. Heward JM, Allahabadia A, Sheppard MC, Barnett AH, Franklyn JA, Gough SC: Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501. Clin Endocrinol 1999, 51:115-118.
162. Fling SP, Arp B, Pious D: HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 1994, 368:554-558.
163. Kim TG, Carrington M, Choi HB, Kim HY, Han H: Three HLA-DMB variants in Korean patients with autoimmune diseases. Hum Immunol 1996, 46:58-60.
164. Ostrov DA, Shi W, Schwartz JC, Almo SC, Nathenson SG: Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science 2000, 290:816-819.
165. Chistiakov DA, Turakulov RI: CTLA4 and its role in autoimmune thyroid disease. J Mol Endocrinol 2003, 31:21-36.
166. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, McCarthy MI, Kendall-Taylor P, Pearce SH: The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 1999, 8:1195-1199.
167. Tomer Y, Greenberg DA, Barbesino G, Concepcion E, Davies TF: CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 2001, 86:1687-1693.
168. Allahabadia A, Gough SC: The different approaches to the genetic analysis of autoimmune thyroid disease. J Endocrinol 1999, 163:7-13.
169. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
170. Magistrelli G, Jeannin P, Herbault N, Benoit De Coignac A, Gauchat JF, Bonnefoy JY, Delneste Y: A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 1999, 29:3596-3602.
171. Oaks MK, Hallett KM, Penwell RT, Stauber EC, Warren SJ, Tector AJ: A native soluble form of CTLA-4. Cell Immunol 2000, 201:144-153.
172. Manzotti CN, Tipping H, Perry LC, Mead KI, Blair PJ, Zheng Y, Sansom DM: Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur J Immunol 2002, 32:2888-2896.
173. Oaks MK, Hallett KM: Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 2000, 164:5015-5018.
174. Wang XB, Kakoulidou M, Giscombe R, Qiu Q, Huang D, Pirskanen R, Lefvert AK: Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J Neuroimmunol 2002, 130:224-232.
175. Huang D, Liu L, Noren K, Xia SQ, Trifunovic J, Pirskanen R, Lefvert AK: Genetic association of Ctla-4 to myasthenia gravis with thymoma. J Neuroimmunol 1998, 88:192-198.
176. Anjos S, Nguyen H, Ounissi-Benkalha H, Tessier MC, Polychronakos C: A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 2002, 277:46478-46486.
177. Kouki T, Sawai Y, Gardine AC, Fisfalen ME, Alegre ML, DeGroot LJ: CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves disease. J Immunol 2000, 165:6606-6611.
178. Maurer M, Loserth S, Kolb-Maurer A, Ponath A, Wiese S, Kruse N, Rieckmann P: A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002, 54:1-8.
179. Holopainen PM, Partanen JA: Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. J Immunol 2001, 167:2457-2458.
180. Kouki T, Gardine CA, Yanagawa T, Degroot LJ: Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. J Endocrinol Invest 2002, 25:208-213.
181. Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y: Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 2003, 4:586-593.
182. Wang XB, Zhao X, Giscombe R, Lefvert AK: A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 2002, 3:233-234.
183. Chen CY, Shyu AB: AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 1995, 20:465-470.
184. Thomas M, Karlen S, D'Ercole , Sanderson C: Analysis of the 5' and 3' UTRs in the posttranslational regulation of the interleukin-5 gene. Biochim Biophys Acta 1999, 1444:61-68.
185. Huang D, Giscombe R, Zhou Y, Pirskanen R, Lefvert AK: Dinucleotide repeat expansion in the CTLA-4 gene leads to T-cell hyperreactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol 2000, 105:69-77.
186. Takara M, Kouki T, DeGroot LJ: CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease. Thyroid 2003, 13:1083-1089.
187. Anjos S, Polychronakos C: Mechanisms of genetic susceptibility to type 1 diabetes: beyond HLA. Mol Genet Metab 2004, 81:187-195.
188. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA: Haplotype tagging for the identification of common disease genes. Nat Genet 2001, 29:233-237.
189. Ling V, Wu PW, Finnerty HF, Agostino MJ, Graham JR, Chen S, Jussiff JM, Fisk GJ, Miller CP, Collins M: Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches. Genomics 2001, 78:155-168.
190. Zaletel K, Krhin B, Gaberscek S, Pirnat E, Hojker S: The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease. Thyroid 2002, 12:373-376.
191. Vaidya B, Imrie H, Geatch DR, Perros P, Ball SG, Baylis PH, Carr D, Hurel SJ, James RA, Kelly WF, Kemp EH, Young ET, Weetman AP, Kendall-Taylor P, Pearce SH: Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J Clin Endocrinol Metab 2000, 85:688-691.
192. Kristiansen OP, Larsen ZM, Pociot F: CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 2000, 1:170-184.
193. Harbo HF, Celius EG, Vartdal F, Spurkland A: CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 1999, 53:106-110.
194. Ligers A, Xu C, Saarinen S, Hillert J, Olerup O: The CTLA-4 gene is associated with multiple sclerosis. J Neuroimmunol 1999, 97:182-190.
195. Robles DT, Fain PR, Gottlieb PA, Eisenbarth GS: The genetics of autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 2002, 31:353-368.
196. Fakhfakh F, Maalej A, Makni H, Abid M, Jouida J, Zouali M, Ayadi H: Analysis of immunoglobulin VH and TCR beta polymor phisms in a large family with thyroid autoimmune disorder. Exp Clin Immunogenet 1999, 16:185-191.
197. Nakao Y, Matsumoto H, Miyazaki T, Nishitani H, Takatsuki K, Kasukawa R, Nakayama S, Izumi S, Fujita T, Tsuji K: IgG heavy chain allotypes (Gm) in autoimmune diseases. Clin Exp Immunol 1980, 42:20-26.
198. Uno H, Sasazuki T, Tamai H, Matsumoto H: Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature 1981, 292:768-770.
199. Rasmussen AK: Cytokine actions on the thyroid gland. Dan Med Bull 2000, 47:94-114.
200. Ajjan RA, Watson PF, Weetman AP: Cytokines and thyroid function. Adv Neuroimmunol 1996, 6:359-386.
201. Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JA, Welsh KI: Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000, 85:1984-1988.
202. Blakemore AI, Watson PF, Weetman AP, Duff GW: Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995, 80:111-115.
203. Pearce SH, Cheetham T, Imrie H, Vaidya B, Barnes ND, Bilous RW, Carr D, Meeran K, Shaw NJ, Smith CS, Toft AD, Williams G, Kendall-Taylor P: A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet 1998, 63:1675-1684.
204. Nithiyananthan R, Heward JM, Allahabadia A, Barnett AH, Franklyn JA, Gough SC: A heterozygous deletion of the autoimmune regulator (AIRE1) gene, autoimmune thyroid disease, and type 1 diabetes: no evidence for association. J Clin Endocrinol Metab 2000, 85:1320-1322.
205. Fournier C, Gepner P, Sadouk M, Charreire J: In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 1990, 54:53-63.
206. Hahn HJ, Kuttler B, Mathieu C, Bouillon R: 1,25-Dihydroxyvitamin D3 reduces MHC antigen expression on pancreatic betacells in vitro. Transplant Proc 1997, 29:2156-2157.
207. Pani MA, Regulla K, Segni M, Krause M, Hofmann S, Hufner M, Herwig J, Pasquino AM, Usadel KH, Badenhoop K: Vitamin D 1alphahydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus. Eur J Endocrinol 2002, 146:777-781.
208. Pani MA, Regulla K, Segni M, Hofmann S, Hufner M, Pasquino AM, Usadel KH, Badenhoop K: A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J Clin Endocrinol Metab 2002, 87:2564-2567.
209. Ban Y, Taniyama M, Ban Y: Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab 2000, 85:4639-4643.
210. Ban Y, Taniyama M, Ban Y: Vitamin D receptor gene polymorphisms in Hashimoto's thyroiditis. Thyroid 2001, 11:607-608.
211. Pani MA, Seissler J, Usadel KH, Badenhoop K: Vitamin D receptor genotype is associated with Addison's disease. Eur J Endocrinol 2002, 147:635-640.
212. Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Hamada T, Miyasaka K, Tashiro K: Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci 1999, 166:47-52.
213. Gyorffy B, Vasarhelyi B, Krikovszky D, Madacsy L, Tordai A, Tulassay T, Szabo A: Gender-specific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus. Eur J Endocrinol 2002, 147:803-808.
214. Pedersen IB, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Laurberg P: Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol 2003, 58:36-42.
215. Jaume JC, Guo J, Pauls DL, Zakarija M, McKenzie JM, Egeland JA, Burek CL, Rose NR, Hoffman WH, Rapoport B, McLachlan SM: Evidence for genetic transmission of thyroid peroxidase autoantibody epitopic " fingerprints". J Clin Endocrinol Metab 1999, 84:1424-1431.
216. Pirro MT, De Filippis V, Di Cerbo A, Scillitani A, Liuzzi A, Tassi V: Thyroperoxidase microsatellite polymorphism in thyroid diseases. Thyroid 1995, 5:461-464.
217. Cuddihy RM, Dutton CM, Bahn RS: A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 1995, 5:89-95.
218. Sunthornthepvarakul T, Kitvitayasak S, Ngowngarmaratana S, Konthong P, Deerochanawong C, Sarinnapakorn V, Phongviratchai S: Lack of association between a polymorphism of human thyrotropin receptor gene and autoimmune thyroid disease. J Med Assoc Thai 1999, 82:1214-1219.
219. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF: Linkage analysis of candidate genes in autoimmune thyroid disease. III. Detailed analysis of chromosome 14 localizes Graves' disease-1 (GD-1) close to multinodular goiter-1 (MNG-1). International Consortium for the Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab 1998, 83:4321-4327.
220. Allen EM, Hsueh WC, Sabra MM, Pollin TI, Ladenson PW, Silver KD, Mitchell BD, Shuldiner AR: A genome-wide scan for autoimmune thyroiditis in the Old Order Amish: replication of genetic linkage on chromosome 5q11.2-q14.3. J Clin Endocrinol Metab 2003, 88:1292-1296.
221. Sale MM, Akamizu T, Howard TD, Yokota T, Nakao K, Mori T, Iwasaki H, Rich SS, Jennings-Gee JE, Yamada M, Bowden DW: Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population. Proc Assoc Am Physicians 1997, 109:453-461.
222. Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N, Saijo M, Miyamoto Y, Saito Y, Nakao K, Bowden DW: Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 2000, 10:851-858.
223. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF: Thyroglobulin is a thyroid specific gene for the familial autoimmune diseases. J Clin Endocrinol Metab 2002, 87:404-407.
224. Collins JE, Heward JM, Carr-Smith J, Daykin J, Franklyn JA, Gough SC: Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J Clin Endocrinol Metab 2003, 88:5039-5042.
225. Rivolta CM, Moya CM, Mendive FM, Targovnik HM: Genotyping and characterization of two polymorphic microsatellite markers located within introns 29 and 30 of the human thyroglobulin gene. Thyroid 2002, 12:773-779.
226. Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y: Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A 2003, 100:15119-15124.
227. Ban Y, Tomer Y: The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 2003, 36:367-379.
228. Tomer Y, Greenberg D: The thyroglobulin gene as the first thyroid-specific susceptibility gene for autoimmune thyroid disease. Trends Mol Med 2004, 10:306-308.
229. Wall JD, Pritchard JK: Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 4:587-597.
230. Hutchings PR, Cooke A, Dawe K, Champion BR, Geysen M, Valerio R, Roitt IM: A thyroxine-containing peptide can induce murine experimental autoimmune thyroiditis. J Exp Med 1992, 175:869-872.
231. Champion BR, Rayner DC, Byfield PGH, Page KR, Chan CTJ, Roitt JM: Critical role of iodination for T cell recognition of thyroglobulin in experimental murine thyroid autoimmunity. J Immunol 1987, 139:3665-3670.
232. Kacem HH, Rebai A, Kaffel N, Masmoudi S, Abid M, Ayadi H: PDS is a new susceptibility gene to autoimmune thyroid diseases: association and linkage study. J Clin Endocrinol Metab 2003, 88:2274-2280.
233. Nilsson M: Iodide handling by the thyroid epithelial cell. Exp Clin Endocrinol Diabetes 2001, 109:13-17.
234. Stuck BJ, Pani MA, Besrour F, Segni M, Krause M, Usadel KH, Badenhoop K: Fas ligand gene polymorphisms are not associated with Hashimoto's thyroiditis and Graves' disease. Hum Immunol 2003, 64:285-289.
235. Park WS, Oh RR, Kim YS, Park JY, Lee SH, Shin MS, Kim SY, Kim PJ, Lee HK, Yoo NY, Lee JY: Somatic mutations in the death domain of the Fas (Apo-1/CD95) gene in gastric cancer. J Pathol 2001, 193:162-168.
236. Boldrini L, Loggini B, Gisfredi S, Zucconi Y, Baldinotti F, Fogli A, Simi P, Cervadoro G, Barachini P, Basolo F, Pingitore R, Fontanini G: Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer. J Cutan Med Surg 2003, 7:112-118.
237. Lynch RA, Wagoner L, Li S, Sparks L, Molkentin J, Dorn GW 2nd: Novel and nondetected human signaling protein polymorphisms. Physiol Genomics 2002, 10:159-168.
238. Barbesino G, Tomer Y, Concepcion ES, Davies TF, Greenberg DA: Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab 1998, 83:3290-3295.
239. Ban Y, Taniyama M, Tozaki T, Tomita M, Ban Y: Estrogen receptor alpha dinucleotide repeat polymorphism in Japanese patients with autoimmune thyroid diseases. BMC Med Genet 2000, 1:1.
240. Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y: Lack of association between estrogen receptor beta dinucleotide repeat polymorphism and autoimmune thyroid diseases in Japanese patients. BMC Med Genet 2001, 2:1.
241. Biunno I, Bernard L, Dear P, Cattaneo M, Volorio S, Zannini L, Bankier A, Zollo M: SEL1L, the human homolog of C. elegans sel-1: refined physical mapping, gene structure and identification of polymorphic markers. Hum Genet 2000, 106:227-235.
242. Ban Y, Taniyama M, Tozaki T, Yanagawa T, Tomita M, Ban Y: SEL1L microsatellite polymorphism in Japanese patients with autoimmune thyroid diseases. Thyroid 2001, 11:335-338.
243. Field LL, Tobias R, Thomson G, Plon S: Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3-q31. Genomics 1996, 33:1-8.
244. Shirasawa S, Harada H, Furugaki K, Akamizu T, Ishikawa N, Ito K, Ito K, Tamai H, Kuma K, Kubota S, Hiratani H, Tsuchiya T, Baba I, Ishikawa M, Tanaka M, Sakai K, Aoki M, Yamamoto K, Sasazuki T: SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum Mol Genet 2004, 13:2221-2231.
245. Tufarelly C, Stanley JAS, Carrick D, Sharpe JA, Ayyub H, Wood WG, Higgs DR: Transcription of antisense RNA leading to gene silensing and methylation as a novel cause of human genetic disease. Nat Genet 2003, 34:157-165.
246. Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garoccio M, Germain D, Samarut J, Magaud JP: BTG1, a member of a new family of antiproliferative genes. EMBO J 1992, 11:1663-1670.
247. Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T, Alnemri ES: CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 1997, 57:615-619.
248. Delepine M, Pociot F, Habita C, Hashimoto L, Froguel P, Rotter J, Cambon-Thomsen A, Deschamps I, Djoulah S, Weissenbach J, Nerup J, Lathrop M, Julier C: Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am J Hum Genet 1997, 60:174-187.
249. Gaffney PM, Kearns GM, Shark KB, Ortmann WA, Selby SA, Malmgren ML, Rohlf KE, Ockenden TC, Messner RP, King RA, Rich SS, Behrens TW: A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci U S A 1998, 95:14875-14879.
250. Van de Wetering M, Oosterwegel M, van Norren K, Clevers H: Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J 1993, 12:3847-3854.
251. Akamizu T, Hiratani H, Ikegami S, Rich SS, Bowen DW: Association study of autoimmune disease at 5q23-q33 in Japanese patients. J Hum Genet 2003, 48:236-242.
252. Walther A, Riehemann K, Gerke V: A novel ligand of the formyl peptide receptor: annxin I regulates neutrophil extravasation by interacting with FRP. Mol Cell 2000, 5:831-840.
253. Lam E, Martin MM, Timerman AP, Sabers C, Fleischer S, Lukas T, Abraham RT, O'Keefe SJ, O'Neill EA, Wiederrecht GJ: A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. J Biol Chem 1995, 270:26511-26522.
254. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B: A model for p53-induced apoptosis. Nature 1997, 389:300-305.
255. Flynn JC, Rao PV, Gora M, Alsharabi G, Wei W, Giraldo AA, David CS, Banga JP, Kohn LD, Napolitano G, Singer DS, Molteni M, Scorza R, Shimojo N, Kohno Y, Mozes E, Nakazato M, Ulianich L, Chung HK, Matoba H, Saunier B, Suzuki K, Schuppert F, Saji M: Graves' disease: a host defense mechanism gone awry. Int Rev Immunol 2000, 19:633-664.
256. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF: A new Graves disease-susceptibility locus maps to chromosome 20q11.2. Am J Hum Genet 1998, 63:1749-1756.
257. Pearce SH, Vaidya B, Imrie H, Perros P, Kelly WF, Toft AD, McCarthy MI, Young ET, Kendall-Taylor P: Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease. Am J Hum Genet 1999, 65:1462-1465.
258. Tomer Y, Concepcion E, Greenberg DA: A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 2002, 12:1129-1135.
259. Watson PF, Pickerill AP, Davies R, Weetman AP: Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J Clin Endocrinol Metab 1994, 79:355-360.